Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HZT-501

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
OBJECTIVES:We performed two 24-week double-blind trials (REDUCE-1 and -2 (Registration Endoscopic Studies to Determine Ulcer… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Review
2012
Review
2012
  • A. Bello
  • Therapeutic advances in musculoskeletal disease
  • 2012
  • Corpus ID: 36339352
Chronic pain conditions affect at least 116 million US adults and more than one-third of adults worldwide. Nonsteroidal anti… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Review
2012
Review
2012
  • M. Schiff, D. Peura
  • Expert review of gastroenterology & hepatology
  • 2012
  • Corpus ID: 46369253
Arthritis affects nearly 50 million people in the USA and, with the aging of the population, the prevalence is expected to rise… Expand
2011
2011
Introduction The prevention of peptic ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs) is hampered by the high… Expand
2010
2010
HZT-501, a Novel Combination Tablet of Ibuprofen and Famotidine, Provides Pharmacokinetics Comparable to European Commercially… Expand
2009
2009
  • J. Birk, M. Myers
  • Expert opinion on investigational drugs
  • 2009
  • Corpus ID: 30841904
The NSAID class of medications is frequently used for mild to moderate pain. While overall safe, NSAIDs have several important… Expand
Review
2009
Review
2009
Proton pump inhibitors are recommended to decrease NSAID-associated GI injury, while standard-dose histamine2-receptor… Expand